CQ Medical

Welcome to CQ Medical

The company

CanaQuest Medical, an award-winning, life-sciences company, is focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors.

The Company is perfecting formulations and delivery systems to be used in human trials in order to obtain a Drug Identification Number (DIN) from the US-FDA. The Drug Candidate we are pursuing is to treat rare neurological conditions under the umbrella of Epilepsy.
CanaQuest Medical is the industry partner for research and product development with Dr. Steven Laviolette, a professor, and neuroscientist, at Western University, London, Ontario Canada. Dr. Laviolette is a scientific veteran with 20 years of research experience in the field of mental health and cannabinoids and he oversees a dedicated team of 13 scientists. As a result of the positive pre-clinical trial results, conducted by Dr. Laviolette, CanaQuest is introducing Mentanine® (CBD isolate +_omega-3 formula) to support mental health disorders including anxiety, depression, post-traumatic stress disorder (PTSD), and Addiction.  www.laviolettelab.com

Dr. Laviolette stated, “Our CBD-based formulation works synergistically and has multiple times the efficacy compared to other approved CBD products on the market. This discovery sets the stage for substantially smaller dosages of CBD generating the desired results without the negative side effects. There is strong evidence that this formulation is also a very promising anti-epilepsy treatment, which I believe makes the formulation even more promising for these applications.”

Our Advantage

CanaQuest Medical Corporation, a LIFE SCIENCE COMPANY obtains exclusive knowledge of medical cannabinoid therapy, as an industry partner with Western University and the most experienced scientific team led by cannabinoid research veteran, Dr. Steven Laviolette (Professor, Neuroscientist).

Our team’s innovation and patented discoveries help physicians to make recommendations that are based on proven and effective scientific research and pre-clinical trials. We are convinced that this scientific approach can provide the scientific base for innovative formulations to protect patients, help physicians and avoid treatments based on trial and error.

The company’s objective is to educate people about the side effects caused by cannabinoid use and provide safer alternatives.

Our Mentanine® formulation is developed to be an alternative to any other CBD product on the market today. The benefits outlined in the Product Sheet description do not provide any treatment claims. Mentanine® combined with Omega-3s improves the health of the endocannabinoid system (EDC). A healthy EDC can improve general health and in effect can mitigate anxiety and depression.

Mission

Our mission is to build a global cannabinoid brand through education, scientific research, and product development. CanaQuest Medical is committed to being a World-leading cannabinoid treatment provider…and…as a patient-focused LIFE SCIENCE COMPANY, offers the best products for medical cannabinoid care and improving quality of life.

Vision

Driven by our experienced leadership and scientific team, CanaQuest Medical has advanced as a leader, engaged in cutting-edge innovation and, research and development, that will improve the quality of life.

Quality

Engaging in cutting-edge innovation, research, and development.

Trust and respect

Protect patients and physicians and avoid treatments based on trial and error.

Boldness

A global cannabis brand - through education, scientific research, and development.

Integrity and Honesty

An industry partner with Western University and the most experienced scientific team.